← All medicines
COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year
Licence EU/1/20/1528/037-038 · Unknown
- Licence holder
- BioNTech Manufacturing GmbH (all products →)
- Active substance
- COVID-19 mRNA vaccine (nucleoside-modified)
- Dosage form
- Dispersion for injection
- ATC code
- J07BN01
- First authorised
- 21/12/2020
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.